R.R. Donnelley & Sons Company (NYSE: RRD) has been awarded a multi-year $30 million contract renewal by Medbuy Corporation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE